Kardigan IPO status, timeline, valuation and S-1 filing tracker. Last updated July 2026.
| Industry | Heart Health Devices |
| Stage | Series C |
| IPO Status | Private |
| Valuation | $1.2B |
| Total Funding | $550M |
| Headquarters | New York, USA |
| IPO Readiness Score | 44/100 |
| Founded | 2018 |
Track Kardigan IPO status, valuation updates, and S-1 filing milestones on TechStackIPO. Last updated July 2026.
Kardigan is a Heart Health Devices company currently at the Series C stage. The company is tracked by TechStackIPO as a potential IPO candidate in the Heart Health Devices sector.
Kardigan is currently a private company being monitored by TechStackIPO for potential IPO activity. The company’s IPO readiness score is 44/100. Companies in the Heart Health Devices sector have seen significant IPO activity in recent years, with several notable listings and S-1 filings tracked on TechStackIPO. Key factors that could accelerate Kardigan’s path to IPO include revenue growth, profitability milestones, favorable market conditions, and strategic investor interest.
Kardigan is valued at $1.2B based on the most recent private market data. The company has raised a total of $550M in funding. Private market valuations are determined by the latest funding round and may differ from eventual IPO pricing, which reflects public market conditions, investor demand, and comparable company multiples at the time of listing.
Funding rounds from seed through latest — Series A, B, C and beyond.
| Round | Date | Amount | Valuation | Lead Investor(s) |
|---|---|---|---|---|
| Series C | Jul 2026 | $150M | — | — |
Total funding raised: $550M
Bear / base / bull scenarios based on current private market valuation and comparable IPO multiples.
| Scenario | Est. Valuation | Basis |
|---|---|---|
| Bear | $900M | Compressed multiples, delayed listing |
| Base | $1.2B | Last private round valuation |
| Bull | $1.7B | Strong market, premium AI/tech multiple |
Estimates are illustrative. Not investment advice. All figures based on publicly available data.
Kardigan has an IPO readiness score of 44/100 on TechStackIPO. A moderate readiness score suggests the company may be 2–4 years from IPO.
Kardigan's last known private valuation is $1.2B. IPO valuations typically reflect current market conditions at time of listing and may differ from private market valuations.
Pre-IPO access options may include: (1) secondary market platforms such as Forge Global or EquityZen that facilitate private share sales, (2) ETFs holding pre-IPO companies or venture portfolios, and (3) direct secondary share purchases if eligible as an accredited investor. TechStackIPO tracks availability but does not facilitate investments.
No. Kardigan has not yet filed an S-1 registration statement with the SEC as of TechStackIPO's latest data update.
Kardigan operates in the Heart Health Devices sector. TechStackIPO tracks multiple Heart Health Devices companies from seed through IPO, including their funding rounds, valuations, and IPO readiness scores. You can compare Kardigan against other Heart Health Devices companies using TechStackIPO's comparison tool.
Kardigan is at the Series C stage. The company has raised a total of $550M in funding. Companies at this funding stage are typically scaling operations, expanding market share, and evaluating public market timing.
Kardigan is headquartered in New York, USA. The company's location can influence IPO exchange selection, regulatory requirements, and investor interest. Companies headquartered in major tech hubs often benefit from proximity to venture capital networks and talent pools.